Ginkgo Biloba for Mild Cognitive Impairment and Alzheimer’s Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

By  

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 5, 2016-02 ,pp. : 520-528

Bentham Science Publishers

Access to resources Recommend Favorite

Efficacy and safety of sertindole in two double-blind, placebo-controlled trials of schizophrenic patients

By Targum S.   Zborowski J.   Henry M.   Schmitz P.   Sebree T.   Wallin B.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 348-349

Elsevier

Access to resources Recommend Favorite

Psychiatric Adverse Events in Randomized, Double-Blind, Placebo-Controlled Clinical Trials of Varenicline: A Pooled Analysis

By Tonstad Serena  

Drug Safety, Vol. 33, Iss. 4, 2010-04 ,pp. : 289-301

Adis International

Access to resources Recommend Favorite

Use of double-blind placebo-controlled N-of-1 trials among stimulant-treated youths in The Netherlands: a descriptive study

By Faber Adrianne   Keizer Ron   Berg Paul   Jong-van den Berg Lolkje   Tobi Hilde  

European Journal of Clinical Pharmacology, Vol. 63, Iss. 1, 2007-01 ,pp. : 57-63

Springer Publishing Company

Access to resources Recommend Favorite

Nicergoline in the long term treatment of mild or moderate senile dementia. A multicenter double-blind, randomized, placebo-controlled trial

By Nicergoline Dementia Long Term Study Italian Group   Battaglia A.   Annoni K.   Pamparana F.   De Paolis C.   Bonura M.L.   Stekke W.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 383-383

Elsevier

Access to resources Recommend Favorite